Rhinitis, Allergic: Clinical Trials

6 trials for Rhinitis, Allergic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 11Terminated 1

Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Study for Allergy Relief Onset
Chlorpheniramine maleate (BAY X002134), Placebo - Rhinitis, Allergic
Phase 2TerminatedBayer12016-05-072018-12-12
Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma
Depigoid® (500 DPP/ml) - Allergic Rhinitis, Rhinoconjunctivitis
Phase 2TerminatedLaboratorios Leti, S.L.82012-06-012018-02-23
Comparison of Different Up-dosing Schedules With Osiris
OSIRIS, OSIRIS other concentration 1, OSIRIS other concentration 2 - Allergic Rhinitis
Phase 2TerminatedALK-Abelló A/S2102010-12-012011-08-29
Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen
AllerT SC, AllerT ID, Placebo SC - Allergic Rhinitis, Allergy
Phase 1 / Phase 2TerminatedAnergis292008-08-012012-11-20
Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults
Amb a 1 immunostimulatory oligodeoxyribonucleotide conjugate, Histamine base - Rhinitis, Allergic, Seasonal
Phase 2TerminatedDynavax Technologies Corporation7382006-04-012019-04-16
Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC) - Asthma, Allergy
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)1402006-04-012013-02-05

Narrower conditions

Hypersensitivity (3)  ·  Asthma (2)  ·  Rhinitis (2)  ·  Rhinitis, Allergic, Seasonal (2)  ·  Respiratory Sounds (1)

Broader conditions

Hypersensitivity, Immediate (6)  ·  Immune System Diseases (6)  ·  Nose Diseases (6)  ·  Otorhinolaryngologic Diseases (6)  ·  Respiratory Hypersensitivity (6)  ·  Respiratory Tract Diseases (6)  ·  Rhinitis (4)  ·  Hypersensitivity (3)  ·  Bronchial Diseases (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Respiratory Tract Infections (2)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Chlorpheniramine (1)  ·  Osi21 protein, Drosophila (1)

Sponsors

ALK-Abelló A/S (1)  ·  Anergis (1)  ·  Bayer (1)  ·  Dynavax Technologies Corporation (1)  ·  Laboratorios Leti, S.L. (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (3)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

David Broide, MD (1)  ·  Eduardo Martins, MD, DPhil (1)  ·  Francois Spertini, MD (1)  ·  Peter Creticos, MD (1)